New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Waites KB, Talkington DF: Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev.17(4),697–728 (2004).▪▪ Comprehensive review of all aspects of human infections owing to Mycoplasma pneumoniae that includes in-depth discussions of clinical and epidemiological aspects as well as diagnostic strategies.
  Medline CASGoogle Scholar
• 2  Waldo RH 3rd, Krause DC: Synthesis, stability, and function of cytadhesin P1 and accessory protein B/C complex of Mycoplasma pneumoniae. J. Bacteriol.188(2),569–575 (2006).
  Medline CASGoogle Scholar
• 3  Krause DC, Balish MF: Cellular engineering in a minimal microbe: structure and assembly of the terminal organelle of Mycoplasma pneumoniae. Mol. Microbiol.51(4),917–924 (2004).
  Medline CASGoogle Scholar
• 4  Balish MF: Subcellular structures of mycoplasmas. Front. Biosci.11,2017–2027 (2006).
  Medline CASGoogle Scholar
• 5  Balish MF, Krause DC: Mycoplasmas: a distinct cytoskeleton for wall-less bacteria. J. Mol. Microbiol. Biotechnol.11(3–5),244–255 (2006).▪ Describes the mycoplasmal cytoskeletal structures and protein components of the attachment organelle and how they might interact and contribute to its various functions. These processes are essential for cytadherence, the primary virulence factor responsible for M. pneumoniae respiratory disease.
  Medline CASGoogle Scholar
• 6  Henderson GP, Jensen GJ: Three-dimensional structure of Mycoplasma pneumoniae’s attachment organelle and a model for its role in gliding motility. Mol. Microbiol.60(2),376–385 (2006).
  Medline CASGoogle Scholar
• 7  Seybert A, Herrmann R, Frangakis AS: Structural analysis of Mycoplasma pneumoniae by cryo-electron tomography. J. Struct. Biol.156(2),342–354 (2006).
  Medline CASGoogle Scholar
• 8  Kenri T, Seto S, Horino A, Sasaki Y, Sasaki T, Miyata M: Use of fluorescent-protein tagging to determine the subcellular localization of Mycoplasma pneumoniae proteins encoded by the cytadherence regulatory locus. J. Bacteriol.186(20),6944–6955 (2004).
  Medline CASGoogle Scholar
• 9  Hasselbring BM, Krause DC: Proteins P24 and P41 function in the regulation of terminal-organelle development and gliding motility in Mycoplasma pneumoniae. J. Bacteriol.189(20),7442–7449 (2007).
  Medline CASGoogle Scholar
• 10  Hasselbring BM, Krause DC: Cytoskeletal protein P41 is required to anchor the terminal organelle of the wall-less prokaryote Mycoplasma pneumoniae. Mol. Microbiol.63(1),44–53 (2007).
  Medline CASGoogle Scholar
• 11  Hatchel JM, Balish MF: Attachment organelle ultrastructure correlates with phylogeny, not gliding motility properties, in Mycoplasma pneumoniae relatives. Microbiology154(Pt 1),286–295 (2008).
  Medline CASGoogle Scholar
• 12  Seto S, Kenri T, Tomiyama T, Miyata M: Involvement of P1 adhesin in gliding motility of Mycoplasma pneumoniae as revealed by the inhibitory effects of antibody under optimized gliding conditions. J. Bacteriol.187(5),1875–1877 (2005).
  Medline CASGoogle Scholar
• 13  Hasselbring BM, Jordan JL, Krause DC: Mutant analysis reveals a specific requirement for protein P30 in Mycoplasma pneumoniae gliding motility. J. Bacteriol.187(18),6281–6289 (2005).
  Medline CASGoogle Scholar
• 14  Pereyre S, Charron A, Renaudin H, Bebear C, Bebear CM: First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J. Clin. Microbiol.45(11),3534–3539 (2007).
  Medline CASGoogle Scholar
• 15  Musatovova O, Kannan TR, Baseman JB: Genomic analysis reveals Mycoplasma pneumoniae repetitive element 1-mediated recombination in a clinical isolate. Infect. Immun.76(4),1639–1648 (2008).
  Medline CASGoogle Scholar
• 16  Dumke R, Luck PC, Noppen C et al.: Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J. Clin. Microbiol.44(7),2567–2570 (2006).
  Medline CASGoogle Scholar
• 17  Halbedel S, Hames C, Stulke J: In vivo activity of enzymatic and regulatory components of the phosphoenolpyruvate:sugar phosphotransferase system in Mycoplasma pneumoniae. J. Bacteriol.186(23),7936–7943 (2004).
  Medline CASGoogle Scholar
• 18  Merzbacher M, Detsch C, Hillen W, Stulke J: Mycoplasma pneumoniae HPr kinase/phosphorylase. Eur. J. Biochem.271(2),367–374 (2004).
  Medline CASGoogle Scholar
• 19  Rhee SG: Cell signaling. H₂O₂, a necessary evil for cell signaling. Science312(5782),1882–1883 (2006).
  MedlineGoogle Scholar
• 20  Kannan TR, Provenzano D, Wright JR, Baseman JB: Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect. Immun.73(5),2828–2834 (2005).▪ First description of toxin production by M. pneumoniae as a pathogenic mechanism.
  Medline CASGoogle Scholar
• 21  Kannan TR, Baseman JB: ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc. Natl Acad. Sci. USA103(17),6724–6729 (2006).
  Medline CASGoogle Scholar
• 22  May M, Papazisi L, Gorton TS, Geary SJ: Identification of fibronectin-binding proteins in Mycoplasma gallisepticum strain R. Infect. Immun.74(3),1777–1785 (2006).
  Medline CASGoogle Scholar
• 23  Waites KB, Simecka JW, Talkington DF, Atkinson TP: Pathogensis of Mycoplasma pneumoniae infections: adaptive immunity, innate immuinity, cell biology and virulence factors. In: Community-acquired Pneumonia. Suttorp N, Welte T, Marre R (Eds). Burkhauser Verlag, Basel, Switzerland, 183–199 (2007).
  Google Scholar
• 24  Meseguer MA, Alvarez A, Rejas MT, Sanchez C, Perez-Diaz JC, Baquero F: Mycoplasma pneumoniae: a reduced-genome intracellular bacterial pathogen. Infect. Genet. Evol.3(1),47–55 (2003).
  MedlineGoogle Scholar
• 25  Hoek KL, Duffy LB, Cassell GH, Dai Y, Atkinson TP: A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells. Microb. Pathog.39(4),149–158 (2005).▪ This study, utilizing a rodent model, investigated the mechanism by which M. pneumoniae initiates asthma through induction of cytokine responses in mast cells and the importance of the P1 adhesin in this process.
  Medline CASGoogle Scholar
• 26  Luo D, Dai Y, Duffy LB, Prescott Atkinson T: Inhibition of message for FceRI α chain blocks mast cell IL-4 production induced by co-culture with Mycoplasma pneumoniae. Microb. Pathog.44,286–292 (2007).
  MedlineGoogle Scholar
• 27  Atkinson TP, Dai Y, Duffy LB: Role of hydrogen peroxide in Mycoplasma pneumoniae-induced mast cell IL-4 production. J. Allergy Clin. Immunol.119,S54 (2007).
  Google Scholar
• 28  Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA: Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell. Biol.17(2),183–189 (2005).
  Medline CASGoogle Scholar
• 29  Luo D, Dai Y, Duffy LB, Atkinson TP: Activation of the human monocytoid cell line THP-1 for cytokine production by Mycoplasma pneumoniae. J. Allergy Clin. Immunol. (2008) (In press).
  MedlineGoogle Scholar
• 30  Shimizu T, Kida Y, Kuwano K: Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-κB through toll-like receptors 1 and 2. Immunology121(4),473–483 (2007).
  Medline CASGoogle Scholar
• 31  Shimizu T, Kida Y, Kuwano K: A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-κB through TLR1, TLR2, and TLR6. J. Immunol.175(7),4641–4646 (2005).
  Medline CASGoogle Scholar
• 32  Shimizu T, Kida Y, Kuwano K: Mycoplasma pneumoniae-derived lipopeptides induce acute inflammatory responses in the lungs of mice. Infect. Immun.76(1),270–277 (2008).
  Medline CASGoogle Scholar
• 33  Christie LJ, Honarmand S, Talkington DF et al.: Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics120(2),305–313 (2007).▪ Explores the role of M. pneumoniae as a cause of encephalitis in children by performing a comprehensive microbiological evaluation of 1988 children. The significant finding was that M. pneumoniae was the most common etiologic agent identified.
  MedlineGoogle Scholar
• 34  Waites KB, Duffy LB, Schwartz S, Talkington DF: Mycoplasma and ureaplasma. In: Clinical Microbiology Procedure Handbook. Isenberg (Ed.). American Society for Microbiology Press, Washington, DC, USA (2004).
  Google Scholar
• 35  Yuki N: Ganglioside mimicry and peripheral nerve disease. Muscle Nerve35(6),691–711 (2007).
  Medline CASGoogle Scholar
• 36  Ang CW, Tio-Gillen AP, Groen J et al.: Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barre syndrome. J. Neuroimmunol.130(1–2),179–183 (2002).
  Medline CASGoogle Scholar
• 37  Narita M, Tanaka H, Togashi T, Abe S: Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae. Pediatr. Neurol.33(2),105–109 (2005).
  MedlineGoogle Scholar
• 38  Stamm B, Moschopulos M, Hungerbuehler H, Guarner J, Genrich GL, Zaki SR: Neuroinvasion by Mycoplasma pneumoniae in acute disseminated encephalomyelitis. Emerg. Infect. Dis.14(4),641–643 (2008).
  MedlineGoogle Scholar
• 39  Ramirez AS, Rosas A, Hernandez-Beriain JA et al.: Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: a case-control study. Rheumatology (Oxford)44(7),912–914 (2005).
  Medline CASGoogle Scholar
• 40  Johnson SM, Bruckner F, Collins D: Distribution of Mycoplasma pneumoniae and Mycoplasma salivarium in the synovial fluid of arthritis patients. J. Clin. Microbiol.45(3),953–957 (2007).
  Medline CASGoogle Scholar
• 41  Roediger WE: Intestinal mycoplasma in Crohn’s disease. Novartis Found. Symp.263,85–93; discussion 93–98, 211–218 (2004).
  Medline CASGoogle Scholar
• 42  Teig N, Anders A, Schmidt C, Rieger C, Gatermann S: Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases. Thorax60(11),962–966 (2005).
  Medline CASGoogle Scholar
• 43  Sutherland ER, Brandorff JM, Martin RJ: Atypical bacterial pneumonia and asthma risk. J. Asthma41(8),863–868 (2004).
  MedlineGoogle Scholar
• 44  Wu Q, Martin RJ, Lafasto S et al.: Toll-like receptor 2 down-regulation in mouse allergic lungs decreases mycoplasma clearance. Am. J. Respir. Crit. Care Med.177(7),720–729 (2008).
  Medline CASGoogle Scholar
• 45  Chaplin D, Zindl C, Duffy LB, Atkinson TP: Clearance of Mycoplasma pneumoniae is impaired in mice with established airway inflammation. J. Allergy Clin. Immunol.119,S132 (2007).
  MedlineGoogle Scholar
• 46  Wu Q, Martin RJ, Rino JG, Breed R, Torres RM, Chu HW: IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect.9(1),78–86 (2007).
  Medline CASGoogle Scholar
• 47  Lai J, Zindl C, Jung Y, Duffy LB, Atkinson TP, Chaplin D: Regulatory role for Gr-1⁺ cells and CD11⁺ cells in lungs of mice. J. Allergy Clin. Immunol.119,S156 (2007).
  Google Scholar
• 48  Martin RJ, Chu HW, Honour JM, Harbeck RJ: Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am. J. Respir. Cell. Mol. Biol.24(5),577–582 (2001).
  Medline CASGoogle Scholar
• 49  Atkinson TP, Duffy LB, Pendley D, Dai Y, Cassell GH: Reduced IgG antibody to Mycoplasma pneumoniae among children with asthma: results of a five year study. J. Allergy Clin. Immunol.115,S171 (2005).
  MedlineGoogle Scholar
• 50  Talkington DF, Shott S, Fallon MT, Schwartz SB, Thacker WL: Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin. Diagn. Lab. Immunol.11(5),862–867 (2004).▪ Comparison of eight commercial enzyme immunoassays providing insight into the relative merits of various products for detection of acute M. pneumoniae infection. Also provides a discussion on benefits and limitations of serological diagnosis in general.
  Medline CASGoogle Scholar
• 51  Ozaki T, Nishimura N, Ahn J et al.: Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates. J. Infect. Chemother.13(4),204–207 (2007).
  Medline CASGoogle Scholar
• 52  Csango PA, Pedersen JE, Hess RD: Comparison of four Mycoplasma pneumoniae IgM-, IgG- and IgA-specific enzyme immunoassays in blood donors and patients. Clin. Microbiol. Infect.10(12),1094–1098 (2004).
  Medline CASGoogle Scholar
• 53  Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas EC, Goossens H: Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the ‘gold standard’. J. Clin. Microbiol.43(5),2277–2285 (2005).
  Medline CASGoogle Scholar
• 54  Saito R, Misawa Y, Moriya K, Koike K, Ubukata K, Okamura N: Development and evaluation of a loop-mediated isothermal amplification assay for rapid detection of Mycoplasma pneumoniae. J. Med. Microbiol.54(Pt 11),1037–1041 (2005).
  Medline CASGoogle Scholar
• 55  Daxboeck F, Khanakah G, Bauer C, Stadler M, Hofmann H, Stanek G: Detection of Mycoplasma pneumoniae in serum specimens from patients with mycoplasma pneumonia by PCR. Int. J. Med. Microbiol.295(4),279–285 (2005).
  Medline CASGoogle Scholar
• 56  Michelow IC, Olsen K, Lozano J, Duffy LB, McCracken GH, Hardy RD: Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia. J. Clin. Microbiol.42(7),3339–3341 (2004).
  Medline CASGoogle Scholar
• 57  Pitcher D, Chalker VJ, Sheppard C, George RC, Harrison TG: Real-time detection of Mycoplasma pneumoniae in respiratory samples with an internal processing control. J. Med. Microbiol.55(Pt 2),149–155 (2006).
  Medline CASGoogle Scholar
• 58  Raty R, Ronkko E, Kleemola M: Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR. J. Med. Microbiol.54(Pt 3),287–291 (2005).
  Medline CASGoogle Scholar
• 59  Gruson D, Pereyre S, Renaudin H, Charron A, Bebear C, Bebear CM: In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively. Antimicrob. Agents Chemother.49(3),1190–1193 (2005).
  Medline CASGoogle Scholar
• 60  Matsuoka M, Narita M, Okazaki N et al.: Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother.48(12),4624–4630 (2004).▪▪ Describes the emergence of macrolide resistance among clinical isolates of M. pneumoniae in Japan in the early 2000s. Molecular investigation of resistant strains proved the mechanism of resistance to be associated with mutations in ribosomal proteins.
  Medline CASGoogle Scholar
• 61  Suzuki S, Yamazaki T, Narita M et al.: Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob. Agents Chemother.50(2),709–712 (2006).
  Medline CASGoogle Scholar
• 62  Morozumi M, Hasegawa K, Kobayashi R et al.: Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob. Agents Chemother.49(6),2302–2306 (2005).
  Medline CASGoogle Scholar
• 63  Morozumi M, Iwata S, Hasegawa K et al.: Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob. Agents Chemother.52(1),348–350 (2008).
  Medline CASGoogle Scholar
• 64  Wolff BJ, Thacker WL, Schwartz SB, Winchell JM: Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high resolution melt analysis. Antimicrob. Agents Chemother.52,3542–3549 (2008).
  Medline CASGoogle Scholar
• 65  Waites KB, Duffy LB, Bebear CM et al.: Development of agar dilution MIC quality control ranges for antimicrobials tested against Mycoplasma pneumoniae. Presented at: 16th Congress of the International Organization for Mycoplasmology. Cambridge, UK, 9–14 July (2006).
  Google Scholar
• 66  Waites KB, Duffy LB, Bebear C et al.: Development of broth diution MIC quality control ranges for antimicrobial agents tested against Mycoplasma pneumoniae. Presented at: 16th Congress of the International Organization for Mycoplasmology. Cambridge, UK, 9–14 July (2006).
  Google Scholar